Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C6ZX
|
||||
| Former ID |
DIB010981
|
||||
| Drug Name |
KW-3357
|
||||
| Synonyms |
Coagulation factor inhibitor (iv, blood clotting disorder), Kyowa; Recombinant antithrombin (iv, blooding clottingdisorder), Kyowa Hakko Kirin
|
||||
| Indication | Blood coagulation disorders [ICD10:D65-D68] | Phase 3 | [523533] | ||
| Company |
Kyowa Hakko Kogyo Co Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Antithrombin-III | Target Info | Modulator | ||
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Blood coagulation | ||||
| Pathway Interaction Database | Glypican 1 network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.